Is Impinj Inc (PI) Overvalued After 6.8% Rally? GF Value Says Overvalued
On May 22, 2026, Impinj Inc (PI) shares rose 6.8%, closing at $149.76. This positive movement comes amid a 52-week range that has seen a high of $247.06 and a l
PI - Impinj, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$180.00
DETAILS
HIGH:
$220.00
LOW:
$144.00
MEDIAN:
$175.00
CONSENSUS:
$180.00
UPSIDE:
20.19%
Stock News
Impinj Inc (PI) Stock Down 4.7% but Still Overvalued -- GF Score: 73/100
On May 19, 2026, Impinj Inc (PI) shares fell 4.7% today, bringing the current price to $132.74. The stock has experienced a 52-week range from a low of $87.36 t
This Beaten-Down Chip Stock Just Did Something It Hasn't Done in a Year. Time to Buy?
The catalyst lifted the chip stock to a 27% gain in the last two weeks.
How Impinj Stock Jumped 20.5% Today
Impinj posted falling profits but still beat expectations. Here's why investors celebrated the report.
This Chip Maker's Stock Is Soaring After Earnings. Analysts See 20% More Upside.
Chip maker Impinj is surging after beating earnings estimates and isuing better-than-expected second-quarter guidance.
Impinj, Inc. (PI) Q1 2026 Earnings Call Transcript
Impinj, Inc. (PI) Q1 2026 Earnings Call Transcript
Impinj (PI) Tops Q1 Earnings and Revenue Estimates
Impinj (PI) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.21 per share a year ago.
Impinj Reports First Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Impinj Reports First Quarter 2026 Financial Results.
Impinj Inc (PI) Shares Fall 3.8% -- What GF Score of 80 Tells Investors
On April 10, 2026, Impinj Inc (PI) shares fell 3.8% to a current price of $101.54. The stock has fluctuated between a 52-week high of $247.06 and a low of $62.9
Comparing Impinj (NASDAQ:PI) & Tower Semiconductor (NASDAQ:TSEM)
Impinj (NASDAQ: PI - Get Free Report) and Tower Semiconductor (NASDAQ: TSEM - Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability. Risk and Volatility Impinj has a beta
Contrasting Impinj (NASDAQ:PI) and Ceva (NASDAQ:CEVA)
Impinj (NASDAQ: PI - Get Free Report) and Ceva (NASDAQ: CEVA - Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Analyst Ratings This is a breakdown of recent
Analyzing Allegro MicroSystems (NASDAQ:ALGM) and Impinj (NASDAQ:PI)
Allegro MicroSystems (NASDAQ: ALGM - Get Free Report) and Impinj (NASDAQ: PI - Get Free Report) are both mid-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Profitability This table compares Allegro MicroSystems
Impinj to Announce First-Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Impinj to Announce First-Quarter 2026 Financial Results.
Wealth Enhancement Advisory Services LLC Buys 13,759 Shares of Impinj, Inc. $PI
Wealth Enhancement Advisory Services LLC raised its position in Impinj, Inc. (NASDAQ: PI) by 85.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 29,889 shares of the company's stock after buying an additional 13,759 shares during the period. Wealth Enhancement Advisory Services LLC owned
Impinj Announces Partial Repurchase of 1.125% Convertible Notes due 2027
SEATTLE--(BUSINESS WIRE)--Impinj Announces Partial Repurchase of 1.125% Convertible Notes due 2027.
Royce Smaller-Companies Growth Fund FY 2025: What Worked
Nine of the portfolio's 10 equity sectors made a positive impact on performance, with Health Care, Industrials, and Materials making the largest positive contributions. Palvella's shares appreciated significantly in 2025 as investors grew more confident in the company's pipeline following a grant from the FDA, patent wins, and a positive Phase II readout. Impinj is a long time holding in the portfolio with a very large total addressable market expansion opportunity, a strong patent portfolio, and an increasingly diversified customer base.
This Fund Bet $20 Million on an IoT Stock Last Quarter. Shares Have Tanked Nearly 50% This Year
This technology firm enables real-time wireless identification and tracking for clients across retail, logistics, healthcare, and more.
Breakfast News: Top Rule Breakers Look To Innovate
Vertex pops on fast-track chances, Oracle leads notable Tuesday earnings, and more
DLD Asset Management LP Sells 12,250,000 Shares of Impinj, Inc. $PI
DLD Asset Management LP reduced its position in shares of Impinj, Inc. (NASDAQ: PI) by 51.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,750,000 shares of the company's stock after selling 12,250,000 shares during the period. Impinj makes
Citigroup Inc. Sells 17,656 Shares of Impinj, Inc. $PI
Citigroup Inc. reduced its position in Impinj, Inc. (NASDAQ: PI) by 60.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,681 shares of the company's stock after selling 17,656 shares during the quarter. Citigroup Inc.'s holdings in Impinj were worth $2,111,000
Price Targets
Impinj price target raised to $176 from $169 at Barclays
$176.00
(was $144.92)
Barclays
Impinj price target raised to $144 from $112 at Evercore ISI
$144.00
(was $142.28)
Mark Lipacis
·
Evercore ISI
Impinj price target raised to $175 from $155 at UBS
$175.00
(was $120.04)
UBS
Impinj price target lowered to $155 from $190 at UBS
$155.00
(was $153.83)
UBS
Impinj price target lowered to $200 from $255 at Susquehanna
$200.00
(was $110.92)
Christopher Rolland
·
Susquehanna
Impinj price target lowered to $175 from $255 at Needham
$175.00
(was $153.83)
Needham
Impinj price target lowered to $170 from $246 at Cantor Fitzgerald
$170.00
(was $153.83)
Troy Jensen
·
Cantor Fitzgerald
Impinj downgraded to In Line from Outperform at Evercore ISI
$112.00
(was $153.83)
Mark Lipacis
·
Evercore ISI
Impinj price target lowered to $175 from $211 at Barclays
$175.00
(was $153.83)
Barclays
Impinj price target lowered to $220 from $235 at Roth Capital
$220.00
(was $153.83)
Roth Capital
Impinj price target lowered to $190 from $200 at UBS
$190.00
(was $162.13)
UBS
Impinj price target raised to $211 from $200 at Barclays
$211.00
(was $175.55)
Barclays
Impinj price target raised to $255 from $235 at Susquehanna
$255.00
(was $218.80)
Susquehanna
Impinj price target raised to $255 from $195 at Needham
$255.00
(was $241.91)
James Ricchiuti
·
Needham
Impinj price target raised to $235 from $165 at Roth Capital
$235.00
(was $241.91)
Scott Searle
·
Roth Capital
Impinj price target raised to $230 from $180 at Piper Sandler
$230.00
(was $202.08)
Piper Sandler
Impinj price target raised to $235 from $180 at Susquehanna
$235.00
(was $200.72)
Susquehanna
Impinj initiated with an Overweight at Barclays
$200.00
(was $192.97)
Barclays
Impinj Inc (PI) PT Raised to $251 at Lake Street Capital Markets
$251.00
(was $203.82)
Troy Jensen
·
Loop Capital Markets
Impinj Inc (PI) PT Raised to $245 at Needham
$245.00
(was $196.40)
James Ricchiuti
·
Needham